Budget Amount *help |
¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
Fiscal Year 2015: ¥3,640,000 (Direct Cost: ¥2,800,000、Indirect Cost: ¥840,000)
|
Outline of Final Research Achievements |
We established a humanized mouse model, in which the immune responses in human endotoxic shock in vivo can be analyzed. By using this model, we examine the effect of anti-human CD300a monoclonal antibody on the endotoxic shock. First, we established a humanized mouse by transfer of human hematopoietic cells into severe immunodeficiency mouse (NOG mouse) and induced sepsis by cecal puncture and ligation. We analyzed survival, ALT, AST, and proinflammatory cytokines and chemokines such as IFNγ, TNF-a, IL-6, and IL-8 by ELISA and immune-beads analyses. These analyses suggest that anti-human CD300a monoclonal antibody is useful for the treatment of human endotoxic shock.
|